Literature DB >> 24978860

The portrait of an adult liver transplant recipient in the United States from 1987 to 2013.

Maria Stepanova1, Homan Wai1, Sammy Saab2, Alita Mishra3, Chapy Venkatesan3, Zobair M Younossi3.   

Abstract

Mesh：

Year:  2014        PMID： 24978860     DOI： 10.1001/jamainternmed.2014.2903

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  9 in total

1.  Treatment of Hepatitis C Virus Infection in Liver Transplant Recipients.

Authors:  Duminda Suraweera; Vinay Sundaram; Sammy Saab
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-01

2.  Resource utilization and survival among Medicare patients with advanced liver disease.

Authors:  Munkhzul Otgonsuren; Linda Henry; Sharon Hunt; Chapy Venkatesan; Alita Mishra; Zobair M Younossi
Journal:  Dig Dis Sci       Date:  2014-08-10       Impact factor: 3.199

3.  Chronic ethanol-mediated hepatocyte apoptosis links to decreased TET1 and 5-hydroxymethylcytosine formation.

Authors:  Chengcheng Ji; Katsuya Nagaoka; Jing Zou; Sarah Casulli; Shaolei Lu; Kevin Y Cao; Hongyu Zhang; Yoshifumi Iwagami; Rolf I Carlson; Keri Brooks; Jonathan Lawrence; William Mueller; Jack R Wands; Chiung-Kuei Huang
Journal:  FASEB J       Date:  2018-09-06       Impact factor: 5.191

4.  Long-term outcomes of liver transplantation in patients with hepatitis C infection are not affected by HCV positivity of a donor.

Authors:  Maria Stepanova; Mehmet Sayiner; Leyla de Avila; Zahra Younoszai; Andrei Racila; Zobair M Younossi
Journal:  BMC Gastroenterol       Date:  2016-11-15       Impact factor: 3.067

5.  Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease.

Authors:  Zobair M Younossi; Maria Stepanova; Nila Rafiq; Linda Henry; Rohit Loomba; Hala Makhlouf; Zachary Goodman
Journal:  Hepatol Commun       Date:  2017-06-06

Review 6.  Depression and Chronic Liver Diseases: Are There Shared Underlying Mechanisms?

Authors:  Xiaoqin Huang; Xiaoyun Liu; Yongqiang Yu
Journal:  Front Mol Neurosci       Date:  2017-05-08       Impact factor: 5.639

7.  Risk of de novo post-transplant type 2 diabetes in patients undergoing liver transplant for non-alcoholic steatohepatitis.

Authors:  Maria Stepanova; Linda Henry; Rishi Garg; Shirley Kalwaney; Sammy Saab; Zobair Younossi
Journal:  BMC Gastroenterol       Date:  2015-12-15       Impact factor: 3.067

8.  MELD score as a predictor of mortality, length of hospital stay, and disease burden: A single-center retrospective study in 39,323 inpatients.

Authors:  Jan A Roth; Carl Chrobak; Sabine Schädelin; Balthasar L Hug
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.817

9.  Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis: Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016.

Authors:  Pegah Golabi; Haley Bush; Maria Stepanova; Cameron T Locklear; Ira M Jacobson; Alita Mishra; Gregory Trimble; Madeline Erario; Chapy Venkatesan; Issah Younossi; Zachary Goodman; Zobair M Younossi
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.